微创机器人-B(02252)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02252 微创机器人-B

已收盘 04-30 16:08:13

31.020

-0.440

-1.40%

最高31.920	最低30.660	成交量312.22万
今开31.060	昨收31.460	日振幅4.01%
总市值319.92亿	流通市值317.87亿	总股本10.31亿
成交额9,733万	换手率0.30%	流通股本10.25亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02252","market":"HK","secType":"STK","nameCN":"微创机器人-B","latestPrice":31.02,"timestamp":1777536493003,"preClose":31.46,"halted":0,"volume":3122182,"delay":0,"changeRate":-0.013986013986014026,"floatShares":1024730788,"shares":1031330331,"eps":-0.2801918035314209,"marketStatus":"已收盘","change":-0.44,"latestTime":"04-30 16:08:13","open":31.06,"high":31.92,"low":30.66,"amount":97329700,"amplitude":0.040051,"askPrice":31.02,"askSize":1500,"bidPrice":31,"bidSize":11500,"shortable":3,"etf":0,"ttmEps":-0.2801918035314209,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777858200000},"marketStatusCode":5,"adr":0,"listingDate":1635782400000,"exchange":"SEHK","adjPreClose":31.46,"openAndCloseTimeList":[[1777512600000,1777521600000],[1777525200000,1777536000000]],"volumeRatio":0.732533,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02252","defaultTab":"news","newsList":[{"id":"1171632956","title":"上海微创医疗机器人（集团）股份有限公司2025年经营：收入翻倍增长，亏损大幅收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=1171632956","media":"公告速递","labels":["dataReport","SGX"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171632956?lang=zh_cn&edition=full","pubTime":"2026-04-30 16:41","pubTimestamp":1777538480,"startTime":"0","endTime":"0","summary":"2025年度，上海微创医疗机器人（集团）股份有限公司在手术机器人核心技术布局与海外市场开拓的推动下，实现营业收入约5.51亿元人民币，较2024年度的约2.57亿元同比增长114%以上，并较2023年度的约1.05亿元增长逾四倍。毛利由2024年度的约8,622万元增长至2025年度的约2.67亿元，规模进一步扩大。受益于收入提升及费用优化，税前亏损由2024年度约6.47亿元减少至2025年度的约2.54亿元，降幅超过六成。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"上海微创医疗机器人（集团）股份有限公司2025年经营：收入翻倍增长，亏损大幅收窄","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02252"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630364329","title":"高盛：内地CDMO板块稳健 看好药明康德(02359)、凯莱英(06821)等","url":"https://stock-news.laohu8.com/highlight/detail?id=2630364329","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630364329?lang=zh_cn&edition=full","pubTime":"2026-04-27 17:25","pubTimestamp":1777281907,"startTime":"0","endTime":"0","summary":"股份方面，该行对评级为“买入”的股份持更正面态度，包括药明康德 、凯莱英 、微创机器人 及精锋医疗 。另外，该行将爱康医疗 评级升至“买入”，反映其执行力重启、利润率改善及中期能见度更清晰，并将微泰医疗 升级至“中性”，因国内竞争影响优于预期，且有序达成2026年指引。前者受累于持续的VBP相关利润压力及短期增长乏力，后者收入加速回升但仍不明朗，上行空间有限。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434465.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0132","BK1191","LU0348767384.USD","BK0239","LU2125910500.SGD","LU0708995583.HKD","BK1585","LU1969619763.USD","LU0348766576.USD","LU2242644610.SGD","BK1589","BK1617","BK4139","LU2495084118.USD","LU2045819591.USD","LU1808992512.USD","LU0320764599.SGD","LU0173614495.USD","LU1997245177.USD","02252","002821","603259","BK1141","LU2328871848.SGD","LU0052750758.USD","LU1997244956.HKD","LU0287142896.SGD","BK0216","LU0456842615.SGD","02675","BK1576","BK1100","01066","02359","LU1046422090.SGD","LU2488822045.USD","01789","LU1934453819.USD","06821","LU1979443071.USD","LU1328615791.USD","LU1997245094.SGD","CDMO","BK1583","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197896394","title":"微创机器人-B：完成5,989,798股内资股转换为H股，已发行股本相应变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1197896394","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197896394?lang=zh_cn&edition=full","pubTime":"2026-04-24 16:43","pubTimestamp":1777020194,"startTime":"0","endTime":"0","summary":"微创机器人-B（股票代码：02252）于2026年4月24日发布公告，披露已完成将5,989,798股内资股转换为同等数量的H股。该转换相当于公司现有已发行股本的约0.58%。\n转换后，公司于香港联交所上市的H股数量增至1,030,720,586股，同时内资股数量降至609,745股。公司在公告中确认已遵守香港联交所上市规则及相关法律法规。\n本次公告由董事何超签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"微创机器人-B：完成5,989,798股内资股转换为H股，已发行股本相应变动","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02252"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167421345","title":"异动解读 | 微创机器人-B完成H股全流通，盘中股价大跌5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1167421345","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167421345?lang=zh_cn&edition=full","pubTime":"2026-04-24 10:04","pubTimestamp":1776996284,"startTime":"0","endTime":"0","summary":"微创机器人-B今日盘中股价大幅下跌5%，引起了市场的广泛关注。消息面上，微创机器人-B发布公告，宣布合共598.98万股非上市股份已完成转换为H股，并于今日上午在联交所上市交易。此次H股全流通增加了公司股票的流通数量，市场担忧这可能带来一定的抛售压力或稀释效应，从而对股价形成冲击。H股全流通是港股市场的一项重要制度安排，允许境内未上市股份转换为境外上市股份。对于微创机器人-B而言，此次转换完成后，公司股份的流动性将得到提升，但短期内也可能因供应增加而影响股价表现。投资者需关注后续股份解禁及市场承接情况。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02252"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629830296","title":"微创机器人-B(02252)完成H股全流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2629830296","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629830296?lang=zh_cn&edition=full","pubTime":"2026-04-23 22:03","pubTimestamp":1776953020,"startTime":"0","endTime":"0","summary":"智通财经APP讯，微创机器人-B(02252)发布公告，合共598.98万股非上市股份已于2026年4月23日完成转换为H股，该等转换H股将于2026年4月24日上午九时正开始于联交所上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432958.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"微创机器人-B(02252)完成H股全流通","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","02252","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629969700","title":"港股异动 | 微创机器人-B(02252)涨超3% 海外市场新增订单增速加快 公司深耕欧洲核心高端医疗重地","url":"https://stock-news.laohu8.com/highlight/detail?id=2629969700","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629969700?lang=zh_cn&edition=full","pubTime":"2026-04-21 14:31","pubTimestamp":1776753118,"startTime":"0","endTime":"0","summary":"微创机器人-B(02252)涨超3%，截至发稿，涨2.7%，报35.04港元，成交额1.48亿港元。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20260421/20260421143343_71602.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260421/20260421143343_71602.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1431191.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4588","BK4585","BK1100","159891","BK1617","02252","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629087757","title":"【券商聚焦】中信建投：医疗器械板块拐点来临 26年业绩改善个股存在业绩估值修复机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2629087757","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629087757?lang=zh_cn&edition=full","pubTime":"2026-04-21 09:19","pubTimestamp":1776734371,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投研究认为，医疗器械板块拐点已经来临，26年业绩改善个股存在业绩估值修复机会。建议持续关注市场空间大、国产化率低的创新器械赛道，以及并购重组、脑机接口、AI医疗、手术机器人、外骨骼机器人等主题方向的投资机会。潜在催化较多的方向有望出现涨幅数倍的个股，未来AI医疗、脑机接口等也有望成为投资人重点关注的新科技方向。","market":"us","thumbnail":"https://static.szfiu.com/news/20250106/N2I4ZDVmMTM1NjM3MTU3MjA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/N2I4ZDVmMTM1NjM3MTU3MjA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1979495","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1222","BK1591","BK1247","06826","BK0276","BK1502","BK1515","BK1585","BK1615","BK1574","02235","01302","00853","BK1600","09996","601066","BK1100","BK1142","02190","BK1161","BK1610","159883","01066","LU0287142896.SGD","BK1571","BK1189","02252","09997","00241","BK1593","BK1501","BK1617","BK1583","LU0173614495.USD","BK1584","BK1587","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188440478","title":"异动解读 | 瑞银上调评级叠加产品获欧洲认证及政策利好，微创机器人-B盘中大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=1188440478","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188440478?lang=zh_cn&edition=full","pubTime":"2026-04-16 11:11","pubTimestamp":1776309090,"startTime":"0","endTime":"0","summary":"微创机器人-B今日盘中大幅上涨5.24%，引起了市场的广泛关注。消息面上，多重利好因素共同推动了股价的上涨。瑞银近日将微创机器人-B的评级由“中性”上调至“买入”，并将目标价大幅上调至35.9港元，预计公司未来三年收入及盈利将实现高速增长。同时，公司自主研发的鸿鹄骨科手术机器人成功获得欧洲CE认证，成为国内首款获此认证的关节置换手术机器人，标志着其产品国际化取得重要突破。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02252"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185904218","title":"异动解读 | 微创机器人-B盘中大涨6.53%，政策利好叠加瑞银唱好及产品获欧洲认证","url":"https://stock-news.laohu8.com/highlight/detail?id=1185904218","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185904218?lang=zh_cn&edition=full","pubTime":"2026-04-15 14:13","pubTimestamp":1776233600,"startTime":"0","endTime":"0","summary":"微创机器人-B今日盘中股价大幅上涨6.53%，引起了市场的广泛关注。消息面上，近期手术机器人领域政策支持持续加码，北京市医保局等十部门发布措施推动手术机器人入院，湖南省医保局也明确了相关收费标准，为行业发展注入强心剂。同时，公司自主研发的鸿鹄骨科手术机器人成功获得欧洲CE认证，成为国内首款获此认证的关节置换手术机器人，标志着其产品国际化取得重要突破。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02252"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627175403","title":"港股异动 | 微创机器人-B(02252)再涨超6% 手术机器人领域利好频传 公司今年营收目标同比翻倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2627175403","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627175403?lang=zh_cn&edition=full","pubTime":"2026-04-15 14:03","pubTimestamp":1776233001,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，微创机器人-B再涨超6%，截至发稿，涨6.4%，报32.24港元，成交额2.67亿港元。消息面上，近期手术机器人领域利好频传，政策支持持续加码。业内人士认为，手术机器人具备显著临床获益，全球渗透率有望持续提升。该行指出，微创机器人目标在2026年将总收入较2025年翻倍，并预期海外收入占比将从去年的73%提升至80%以上，有望推动公司在2026年上半年达致收支平衡。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428707.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02252","VXUS","ROBO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627989804","title":"港股异动 | 微创机器人-B(02252)涨超3% 去年图迈手术机器人销量增超5倍 机构看好公司海外销售潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2627989804","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627989804?lang=zh_cn&edition=full","pubTime":"2026-04-14 09:39","pubTimestamp":1776130786,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，微创机器人-B涨超3%，截至发稿，涨2.87%，报28.68港元，成交额995.57万港元。消息面上，瑞银最新研究报告指出，该行看好微创机器人-B强劲的海外销售潜力，公司去年海外收入按年增长287%，其中“图迈”手术机器人销售量更增长超过5倍。瑞银续指，微创机器人-B目标在2026年将总收入较2025年翻倍，并预期海外收入占比将从去年的73%提升至80%以上，有望推动公司在2026年上半年达致收支平衡。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428076.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","ROBO","02252","VXUS","BK4588","BK1617","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627438146","title":"瑞银：微创机器人-B(02252)海外销售强劲 料上半年收支平衡 升至“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2627438146","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627438146?lang=zh_cn&edition=full","pubTime":"2026-04-13 16:02","pubTimestamp":1776067363,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，瑞银发布研报称，将微创机器人-B目标价由21.4港元上调至35.9港元;评级从“中性”升为“买入”; 料集团2026至2028年的预测收入年复合增长率达49.5%，每股盈利年复合增长率高达185.5%，看好其强劲的海外销售潜力。瑞银指出，微创机器人目标在2026年将总收入较2025年翻倍，并预期海外收入占比将从去年的73%提升至80%以上，有望推动公司在2026年上半年达致收支平衡。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1427695.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02252"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626150275","title":"港股异动 | 微创机器人-B(02252)涨超4% 26年图迈手术机器人装机至少200台 海外市场仍是核心增长引擎","url":"https://stock-news.laohu8.com/highlight/detail?id=2626150275","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626150275?lang=zh_cn&edition=full","pubTime":"2026-04-10 10:45","pubTimestamp":1775789132,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，微创机器人-B涨超4%，截至发稿，涨3.44%，报28.28港元，成交额4244.15万港元。该行表示，截至4月初，公司已安装23台图迈手术机器人，并持有86台在手订单。管理层指引上半年安装约103台至113台，全年至少200台，并表明去年下半年的交付瓶颈已解决。海外市场将继续是核心增长引擎，需求遍及欧洲、亚洲及拉丁美洲。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1426924.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","BK1617","BK4588","BK4585","BK1100","ROBO","02252"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626890057","title":"微创机器人携全产品矩阵亮相，国产手术机器人实现全赛道商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=2626890057","media":"广州日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626890057?lang=zh_cn&edition=full","pubTime":"2026-04-09 17:09","pubTimestamp":1775725782,"startTime":"0","endTime":"0","summary":"4月9日—12日，第93届中国国际医疗器械博览会（CMEF）在上海国家会展中心举行。上海微创医疗机器人（集团）股份有限公司携全产品矩阵重磅参展，系统呈现我国手术机器人产业的全景式创新生态与演进路径。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604093699638569.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02252","ROBO","BK1100","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117568062","title":"微创机器人-B更新3月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1117568062","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117568062?lang=zh_cn&edition=full","pubTime":"2026-04-08 16:57","pubTimestamp":1775638657,"startTime":"0","endTime":"0","summary":"上海微创医疗机器人（集团）股份有限公司于2026年4月8日披露了截至2026年3月31日的股份变动月报表。该公司报告期内注册股本总额为人民币1,031,330,331元，包括内资股6,599,543股及H股1,024,730,788股，各类股份数量本月均无增减变化。报告显示，当月未发生新增发行、购回或注销等股份变动。公司未进行任何股本购回或累计库存股份行为，整体股本结构维持稳定。当月未有任何以现金或其他形式取得股份的变动记录。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02252"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625916037","title":"小摩：升微创机器人-B(02252)目标价至42港元 评级“增持”","url":"https://stock-news.laohu8.com/highlight/detail?id=2625916037","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625916037?lang=zh_cn&edition=full","pubTime":"2026-04-08 16:06","pubTimestamp":1775635565,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，摩根大通发布研报称，上调微创机器人-B2026至28年间毛利率假设介乎5至6个百分点，维持微创机器人2026年收入预测14亿元，目标价由41港元上调至42港元，评级“增持”，并为医疗科技行业首选股。该行表示，截至4月初，公司已安装23台图迈手术机器人，并持有86台在手订单。另外，该行重申对迈瑞医疗及微创医疗“增持”评级; 对心脉医疗 予“中性”评级，对微电生理予减持评级。小摩对微创医疗目标价由18.2港元降至18港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425946.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["EWH","02252"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625984549","title":"直击业绩会｜微创机器人2025年营收翻倍，管理层：海外收入占比超七成，今年公司有望盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=2625984549","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625984549?lang=zh_cn&edition=full","pubTime":"2026-04-07 12:54","pubTimestamp":1775537668,"startTime":"0","endTime":"0","summary":"海外业务营收占七成资料显示，微创机器人是微创医疗科学有限公司旗下子集团，2014年作为集团内部孵化项目启动研发腔镜手术机器人，2015年在中国成立公司。2021年微创机器人在香港联交所主板上市。2025年，微创机器人的海外业务成为最强劲的增长引擎。管理层介绍称，报告期内，海外市场销售收入突破4亿元，同比增长287%，海外市场收入占比提升至73%，成为公司收入增长的核心驱动力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604073696315122.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604073696315122.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02252"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625998985","title":"国泰海通：手术机器人全球市场快速拓展 国产厂商具备差异化竞争优势","url":"https://stock-news.laohu8.com/highlight/detail?id=2625998985","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625998985?lang=zh_cn&edition=full","pubTime":"2026-04-07 11:01","pubTimestamp":1775530886,"startTime":"0","endTime":"0","summary":"当前临床试验数据显示国产手术机器人产品有效性安全性比肩达芬奇，国产自主研发制造的手术机器人较达芬奇具备更高性价比优势，同时国产手术机器人厂商亦已在远程手术、“单孔+多孔+远程”一体化等方面获得多项“全球首个”，构建了具备差异化的竞争优势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425367.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["601211","BK1100","BK1147","BK1617","BK0188","BK0183","BK0012","BK0184","02611","BK0201","BK0276","BK1564","ROBO","02252","BK0028","02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622812403","title":"微创机器人：2025年录得收入5.51亿元，核心产品商业化取得突破性进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2622812403","media":"财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622812403?lang=zh_cn&edition=full","pubTime":"2026-03-27 12:20","pubTimestamp":1774585200,"startTime":"0","endTime":"0","summary":"近日，微创机器人发布截至2025年12月31日止年度业绩公告。公司录得收入5.51亿元，同比增长114.2%。毛利为2.67亿元，同比增长209.2%。年内亏损也为2.54亿元，同比减少60.7%。经过调整的净亏损为1.65亿元，同比减少65.8%。公司业绩大幅增长的主要原因是核心产品图迈 腔镜手术机器人商业化取得突破性进展，尤其是在海外市场的销售增长显著，全年新签海外市场订单逾百台，海外市场销售收入为去年的五倍以上，显示出强劲的全球扩张动能。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-03-27/doc-inhsmamz8387772.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-03-27/doc-inhsmamz8387772.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1100","BK1617","02252"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155331967","title":"异动解读 | 微创机器人-B盘中大涨5.16%，2025年业绩亏损大幅收窄、收入翻倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1155331967","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155331967?lang=zh_cn&edition=full","pubTime":"2026-03-27 09:45","pubTimestamp":1774575958,"startTime":"0","endTime":"0","summary":"微创机器人-B(02252.HK)今日盘中大涨5.16%，引起了市场的广泛关注。消息面上，公司发布了2025年度业绩报告。报告显示，公司全年收入达到5.51亿元人民币，同比增长114%。同时，股东应占亏损为2.5亿元，较上年同期的6.42亿元大幅收窄61.1%。业绩的显著改善主要得益于核心产品图迈®腔镜手术机器人商业化取得突破性进展，销售增长迅猛。特别是海外市场拓展成效显著，全年新签海外市场订单超过一百台，海外市场销售收入达到去年的五倍以上，增速远超行业平均水平，展现出强劲的全球扩张动能。这份亮眼的业绩报告提振了投资者对公司未来发展的信心。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02252"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0553},{"period":"1month","weight":0.2241},{"period":"3month","weight":0.1008},{"period":"6month","weight":0.1473},{"period":"1year","weight":0.8419},{"period":"ytd","weight":0.2947}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.055},{"period":"3month","weight":-0.0664},{"period":"6month","weight":0.0079},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.0188}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海微创医疗机器人（集团）股份有限公司是一家主要从事提供智能手术全解方案的中国公司。该公司的主营业务是从事研发、制造及销售手术机器人。该公司的产品包括图迈腔镜手术机器人、鸿鹄骨科手术机器人、R-one血管介入机器人及微创机器人等产品，覆盖腔镜、骨科、泛血管、经自然腔道和经皮穿刺的手术领域。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.03859},{"month":2,"riseRate":0.6,"avgChangeRate":0.111229},{"month":3,"riseRate":0,"avgChangeRate":-0.17011},{"month":4,"riseRate":0.8,"avgChangeRate":0.066517},{"month":5,"riseRate":0,"avgChangeRate":-0.155104},{"month":6,"riseRate":0.75,"avgChangeRate":0.091683},{"month":7,"riseRate":0.5,"avgChangeRate":0.030797},{"month":8,"riseRate":0.25,"avgChangeRate":-0.113179},{"month":9,"riseRate":0.5,"avgChangeRate":0.209266},{"month":10,"riseRate":0.25,"avgChangeRate":-0.026484},{"month":11,"riseRate":0.75,"avgChangeRate":0.08293},{"month":12,"riseRate":0.6,"avgChangeRate":0.026933}],"exchange":"SEHK","name":"微创机器人-B","nameEN":"MEDBOT-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"微创机器人-B(02252)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供微创机器人-B(02252)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"微创机器人-B,02252,微创机器人-B股票,微创机器人-B股票老虎,微创机器人-B股票老虎国际,微创机器人-B行情,微创机器人-B股票行情,微创机器人-B股价,微创机器人-B股市,微创机器人-B股票价格,微创机器人-B股票交易,微创机器人-B股票购买,微创机器人-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"微创机器人-B(02252)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供微创机器人-B(02252)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}